Kimia Biosciences Ltd — Board Meeting, 05-05-2025: Board Meeting

Kimia Biosciences has announced a board meeting that approved the redemption of 0.1% Non-Convertible Cumulative Redeemable Preference Shares held by Enkay Foam Private Limited. The redemption will occur in multiple tranches over six months, funded from distributable profits. The nominal value of redeemed shares will be moved to the Capital Redemption Reserve Account. This move reflects the company's plan to manage its capital structure efficiently, which may positively impact shareholder value.